|
|
Other links at Articles > Infectious Diseases |
| 1. |
Longer-Lasting Mosquito Repellents Identified
|
|
|
Researchers have identified several agents that repel mosquitos up to three times longer than N,N-diethyl-m-toluamide (DEET), the most widely used agent in the world, according to a report in the Proceedings of the National Academy of Sciences for May 27. Reuters Health Information
|
| 3. |
International Approvals: Tasigna, Eraxis, INOmax
|
|
|
Europe has approved nilotinib capsules (Tasigna), Canada has approved anidulafungin intravenous infusion (Eraxis), and Australia has approved nitric oxide for inhalation (INOmax). Medscape Medical News
|
| 4. |
Incidence of Drug-Resistant TB Increasing in the UK
|
|
|
Antituberculosis drug resistance has risen since 1998 in the UK, reflecting greater immigration from TB-endemic regions and inadequate local control of disease transmission, according to figures published on May 2 in BMJ Online First. Reuters Health Information
|
|
|